The prevalence of MS in the United States: a population-based estimate using health claims data

MT Wallin, WJ Culpepper, JD Campbell, LM Nelson… - Neurology, 2019 - AAN Enterprises
Objective To generate a national multiple sclerosis (MS) prevalence estimate for the United
States by applying a validated algorithm to multiple administrative health claims (AHC) …

Diagnoses of depression and anxiety versus current symptoms and quality of life in multiple sclerosis

RA Marrie, SB Patten, LI Berrigan… - … journal of MS care, 2018 - meridian.allenpress.com
Background: Studies assessing the prevalence of depression and anxiety in multiple
sclerosis (MS) have used various ascertainment methods that capture different constructs …

Mortality trends for multiple sclerosis patients in Sweden from 1968 to 2012

S Burkill, S Montgomery, MH Hajiebrahimi, J Hillert… - Neurology, 2017 - AAN Enterprises
Objective: To assess trends in mortality and causes of death for patients with multiple
sclerosis (MS) relative to those without MS in Sweden. Methods: Patients with an MS …

Epidemiology and clinical record of multiple sclerosis in selected countries: a systematic review

N Niedziela, M Adamczyk-Sowa… - International Journal of …, 2014 - Taylor & Francis
Multiple sclerosis (MS) is a chronic inflammatory autoimmune disease of the central nervous
system mainly affecting young adults. The aim of this paper is to review the literature …

A systematic assessment of prevalence, incidence and regional distribution of multiple sclerosis in Bavaria from 2006 to 2015

T Daltrozzo, A Hapfelmeier, E Donnachie… - Frontiers in …, 2018 - frontiersin.org
Introduction: Worldwide, incidence and prevalence of multiple sclerosis (MS) have
increased over the last decades. We present a systematic epidemiological study with recent …

Epidemiology of multiple sclerosis: results from a large observational study in the UK

SS Jick, L Li, GJ Falcone, ZP Vassilev… - Journal of neurology, 2015 - Springer
Multiple sclerosis (MS) progression to mortality may not be solely determined by the
underlying autoimmune process. We conducted a study in a large cohort of MS patients with …

[HTML][HTML] Incidence of cancer in multiple sclerosis before and after the treatment era–a registry-based cohort study

N Grytten, KM Myhr, EG Celius, E Benjaminsen… - Multiple Sclerosis and …, 2021 - Elsevier
Background Whether disease-modifying therapies (DMTs) influence cancer in multiple
sclerosis (MS) is uncertain. Objectives Assess incidence of cancer diagnosis among …

The changing face of multiple sclerosis: prevalence and incidence in an aging population

C Solaro, M Ponzio, E Moran… - Multiple Sclerosis …, 2015 - journals.sagepub.com
Objective: To assess multiple sclerosis (MS) incidence from 1998 to 2007, and MS
prevalence on 31 December 2007, in the province of Genoa, Italy. Methods: We identified …

Rising prevalence of vascular comorbidities in multiple sclerosis: validation of administrative definitions for diabetes, hypertension, and hyperlipidemia

RA Marrie, BN Yu, S Leung, L Elliott… - Multiple Sclerosis …, 2012 - journals.sagepub.com
Background: Despite the importance of comorbidity in multiple sclerosis (MS), methods for
comorbidity assessment in MS are poorly developed. Objective: We validated and applied …

Dramatically changing rates and reasons for hospitalization in multiple sclerosis

RA Marrie, L Elliott, J Marriott, M Cossoy, J Blanchard… - Neurology, 2014 - AAN Enterprises
Objective: We aimed to describe hospitalizations in the multiple sclerosis (MS) population,
and to evaluate temporal trends in hospitalizations in the MS population compared to the …